Para su Difusión
FTC Requires Sale of Generic Cancer Pain Drug and Muscle Relaxant as Conditions of Tevas $6.8 Billion Acquisition of Cephalon
Fecha
To protect competition in the market for prescription drugs, the Federal Trade Commission will require Teva Pharmaceutical Industries Ltd. to sell the rights and assets related to a generic cancer...